Abstract
The Food and Drug Administration warned against fluoroquinolone use for conditions with effective alternative agents. An estimated 5.1% of adult ambulatory fluoroquinolone prescriptions were for conditions that did not require antibiotics, and 19.9% were for conditions where fluoroquinolones are not recommended first-line therapy. Unnecessary fluoroquinolone use should be reduced.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Ambulatory Care*
-
Anti-Bacterial Agents
-
Antimicrobial Stewardship*
-
Bacterial Infections / drug therapy
-
Drug Prescriptions / statistics & numerical data*
-
Fluoroquinolones / administration & dosage*
-
Fluoroquinolones / adverse effects
-
Humans
-
Practice Patterns, Physicians'*
-
United States
-
Virus Diseases
Substances
-
Anti-Bacterial Agents
-
Fluoroquinolones